Akums Drugs & Pharmaceuticals (AKUMS) Share Price falls 5.3% as AKUMS turns lower today
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
AKUMS Share Price was at Rs 778.55, down 5.3% in today’s trade, with Akums Drugs & Pharmaceuticals carrying a market capitalisation of Rs 12,822.89 crore. The move leaves AKUMS Share Price below the previous close of Rs 822.10 and keeps AKUMS Share Price in focus for investors tracking the latest AKUMS Share Price move, the AKUMS Share Price Today action and AKUMS Stock News. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes the day’s decline a factual price event rather than a narrative one, and it places AKUMS Share Price in the centre of short-term stock analysis while the broader valuation backdrop remains relevant for Univest readers.
For Akums Drugs & Pharmaceuticals Share Price, the key point is the size of the intraday move: the stock opened near its previous range, traded between Rs 775.90 and Rs 830.90, and was last seen at Rs 778.55 as of 08 October 2026 at 12:23:01 PM IST. The decline has to be read alongside the company’s Mid Cap classification, its healthcare industry position and its current valuation profile. AKUMS Share Price therefore becomes a live market update story, not because of a stated trigger, but because the price fall is large enough to stand out within the day’s stock market movement. Univest tracks such moves in the context of fundamentals, sector comparisons and peer positioning.
Akums Drugs & Pharmaceuticals (AKUMS) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 778.55 |
| Previous Close | Rs 822.1 |
| Today's Move | -Rs 43.55 (-5.3%) |
| Open | Rs 819.95 |
| High | Rs 830.9 |
| Low | Rs 775.9 |
| Market Capitalisation | Rs 12,822.89 crore |
| Market Cap Category | Mid Cap |
AKUMS Share Price Today shows a clear intraday decline from the previous close. AKUMS Share Price opened at Rs 819.95, touched a high of Rs 830.90 and a low of Rs 775.90 before trading at Rs 778.55. That is a fall of Rs 43.55, or 5.3%, from the previous close of Rs 822.10. The gap between the opening level and the day’s low shows that AKUMS Share Price stayed under pressure through the session’s mid-point, while the final traded price remained close to the day’s low. For investors following AKUMS Share Price Live updates, this is a notable price action event within the Mid Cap category and the market capitalisation of Rs 12,822.89 crore. In Univest terms, the stock has become one of the key healthcare names to watch in today’s market news flow, even without a stated company-specific reason.
AKUMS Share Price today therefore reflects a meaningful reset in near-term price action. The current price, day change and range together show where the stock is trading within the day, while the market cap keeps the company size in view. This is the kind of AKUMS Share Price update that investors use to separate a routine move from an event-led decline. The next layer is fundamentals, where AKUMS Share Price can be examined against profitability, valuation and capital efficiency.
Akums Drugs & Pharmaceuticals (AKUMS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 12,822.89 crore |
| P/E Ratio | 44.36x |
| P/B Ratio | 3.79x |
| ROE | 8.06% |
| ROCE | 14.77% |
| EPS | Rs 18.53 |
| Book Value Per Share | Rs 216.98 |
| Dividend Yield | 0.36% |
Akums Drugs & Pharmaceuticals (AKUMS) fundamental metrics show P/E 44.36x, P/B 3.79x, ROE 8.06%, ROCE 14.77%. These ratios show where the company stands today and are not a call to buy or sell.
Akums Drugs & Pharmaceuticals has a market capitalisation of Rs 12,822.89 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.36x, P/B at 3.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.36%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 44.36x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 3.79x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 8.06% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 14.77% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 12,822.89 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Akums Drugs & Pharmaceuticals (AKUMS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Akums Drugs & Pharmaceuticals (AKUMS) has a P/E ratio of 44.36x, which is above the benchmark median of 31.87x, a difference of +39.19%. A P/E difference of this kind is a reference point rather than a recommendation.
Akums Drugs & Pharmaceuticals (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.61%, a difference of -30.58%. Akums Drugs & Pharmaceuticals (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.46%, a difference of +9.73%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Akums Drugs & Pharmaceuticals (AKUMS) has a P/E ratio of 44.36x compared with the displayed peer median of 82.14x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals (AKUMS) has a market capitalisation of Rs 12,822.89 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Akums Drugs & Pharmaceuticals
- AKUMS Share Price fell 5.3% today, making the latest price move significant for short-term stock watchers.
- The current price of Rs 778.55 sits below the previous close of Rs 822.10, keeping AKUMS Share Price in focus.
- The company’s P/E of 44.36 is above the same-industry median, which keeps valuation part of the AKUMS Share Price discussion.
- ROCE of 14.77% is above the industry median, giving AKUMS Share Price a capital-efficiency reference point.
- AKUMS Share Price is moving within Healthcare and Pharmaceuticals & Drugs, where peer comparisons remain relevant for Univest readers.
About Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is part of the Mid Cap space and is tracked by Univest for AKUMS Share Price, stock market updates and fundamental analysis. Its core business is pharmaceutical manufacturing, and its valuation is currently measured through metrics such as market capitalisation, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value and dividend yield. For AKUMS Share Price, the business context matters because the company’s market position is built around the pharma value chain rather than a broad diversified model.
In Univest coverage, Akums Drugs & Pharmaceuticals Share Price is therefore not just a line item on the screen. It is a company whose market cap, profitability ratios and industry placement can be tracked alongside peers, sector averages and price action. That combination helps readers connect AKUMS Share Price News with the company’s financial profile.
Track AKUMS Share Price on Univest
Use Akums Drugs & Pharmaceuticals (AKUMS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track AKUMS Share Price on Univest for live share price updates, fundamental ratios, 52-week levels and market insights. Univest also helps you follow AKUMS Stock News, AKUMS Latest News and AKUMS Share Price Live in one place. For investors studying AKUMS Share Price Today, the platform brings together price action, valuation context and peer comparisons without requiring separate searches.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did AKUMS Share Price fall today?
Ans. AKUMS Share Price fell 5.3% to Rs 778.55 from the previous close of Rs 822.10. The price move is confirmed in Univest data; a company-specific reason has not been established.
What is AKUMS Share Price today?
Ans. AKUMS Share Price was at Rs 778.55 as of 08 October 2026 at 12:23:01 PM IST. The stock was down Rs 43.55, or 5.3%, in today’s trade. The previous close was Rs 822.1.
What was the day’s range for AKUMS Share Price?
Ans. AKUMS Share Price moved between Rs 775.90 and Rs 830.90 during the day. It opened at Rs 819.95, which shows the stock remained within a clearly defined intraday range. The previous close was Rs 822.1.
What is the market capitalisation of Akums Drugs & Pharmaceuticals?
Ans. Akums Drugs & Pharmaceuticals has a market capitalisation of Rs 12,822.89 crore. It is classified as a Mid Cap company, which places AKUMS Share Price above the industry median market cap.
How is AKUMS valued versus the industry?
Ans. AKUMS Share Price trades at a P/E of 44.36 and P/B of 3.79. That P/E is above the industry median of 31.87 and below the industry average of 48.48. The stock belongs to the Healthcare sector.
What do ROE and ROCE show for AKUMS Share Price?
Ans. AKUMS Share Price has ROE of 8.06% and ROCE of 14.77%. ROE is below the industry median, while ROCE is above the industry median of 13.46%. The previous close was Rs 822.1.
What do EPS, book value and dividend yield mean for AKUMS?
Ans. AKUMS Share Price is backed by EPS of Rs 18.53, book value of Rs 216.98 and dividend yield of 0.36%. These numbers help frame earnings, accounting value and historical income.
How does AKUMS compare with healthcare peers?
Ans. AKUMS Share Price has a lower ROE than peers such as Zydus Lifesciences, Lupin and Torrent Pharmaceuticals. Its P/E is above Cipla, Dr. Reddy’s and Aurobindo Pharma, so valuation sits in the middle range.
Should investors track AKUMS Share Price on Univest?
Ans. Yes, AKUMS Share Price can be tracked on Univest for live updates, valuation ratios, 52-week levels and market insights. That gives a compact view of price action, fundamentals and peer comparison.
